相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition
Matthias G. J. Baud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B
Peiling Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
James Bennett et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
Natalie H. Theodoulou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
Wylie S. Palmer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain
Andrea Unzue et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics
Min Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors
F. Anthony Romero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins
Brigitt Raux et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Laetitia J. Martin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
4-Acyl Pyrrole Derivatives Yield Novel Vectors for Designing Inhibitors of the Acetyl-Lysine Recognition Site of BRD4(1)
Martin Huegle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
Brian K. Albrecht et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions
Thomas Machleidt et al.
ACS CHEMICAL BIOLOGY (2015)
Unexpected Off-Targets and Paradoxical Pathway Activation by Kinase Inhibitors
Oliver Hantschel
ACS CHEMICAL BIOLOGY (2015)
Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules
Andrew K. Urick et al.
ACS CHEMICAL BIOLOGY (2015)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
Peter G. K. Clark et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Sarah Picaud et al.
CANCER RESEARCH (2015)
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNFMutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi et al.
CANCER RESEARCH (2015)
Discovery of Chemical Inhibitors of Human Bromodomains
Guangtao Zhang et al.
CHEMICAL REVIEWS (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Binding Mode of Acetylated Histones to Bromodomains: Variations on a Common Motif
Jean-Remy Marchand et al.
CHEMMEDCHEM (2015)
Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors
Paul Bamborough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
Sarah Picaud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B
Ludovic Drouin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
Emmanuel H. Demont et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors
Xu Ran et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Know your target, know your molecule
Mark E. Bunnage et al.
NATURE CHEMICAL BIOLOGY (2015)
Probing the epigenome
Andrea Huston et al.
NATURE CHEMICAL BIOLOGY (2015)
The promise and peril of chemical probes
Cheryl H. Arrowsmith et al.
NATURE CHEMICAL BIOLOGY (2015)
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Ariane Hammitzsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Molecular Basis of Histone Tail Recognition by Human TIP5 PHD Finger and Bromodomain of the Chromatin Remodeling Complex NoRC
Cynthia Tallant et al.
STRUCTURE (2015)
A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications
E. Megan Flynn et al.
STRUCTURE (2015)
Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains
Duncan A. Hay et al.
MEDCHEMCOMM (2015)
BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536
Lijia Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Target engagement and drug residence time can be observed in living cells with BRET
Matthew B. Robers et al.
NATURE COMMUNICATIONS (2015)
Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
Lei-lei Fu et al.
ONCOTARGET (2015)
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
Marie-Magdelaine Coude et al.
ONCOTARGET (2015)
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
J. M. Gajer et al.
ONCOGENESIS (2015)
Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions
Michael Brand et al.
ACS CHEMICAL BIOLOGY (2015)
The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains
Antje Dittmann et al.
ACS CHEMICAL BIOLOGY (2014)
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
Stuart W. J. Ember et al.
ACS CHEMICAL BIOLOGY (2014)
A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-π Interaction
Timothy P. C. Rooney et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
The bromodomain: From epigenome reader to druggable target
Roberto Sanchez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
Jian Shi et al.
CANCER CELL (2014)
Privileged Diazepine Compounds and Their Emergence as Bromodomain Inhibitors
Steven G. Smith et al.
CHEMISTRY & BIOLOGY (2014)
Nonequivalent Response to Bromodomain-Targeting BET Inhibitors in Oligodendrocyte Cell Fate Decision
Cheng-Ming Chiang
CHEMISTRY & BIOLOGY (2014)
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression
Mar Gacias et al.
CHEMISTRY & BIOLOGY (2014)
Bromodomains and Their Pharmacological Inhibitors
Daniel Gallenkamp et al.
CHEMMEDCHEM (2014)
Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands
Laura E. Jennings et al.
FUTURE MEDICINAL CHEMISTRY (2014)
[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
Oleg Fedorov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Fragment-Based Screening of the Bromodomain of ATAD2
Mary J. Harner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor
Romain Gosmini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors
Michael R. McKeown et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Duncan A. Hay et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Genome-wide localization of small molecules
Lars Anders et al.
NATURE BIOTECHNOLOGY (2014)
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Pietro Ciceri et al.
NATURE CHEMICAL BIOLOGY (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes
Matthias G. J. Baud et al.
SCIENCE (2014)
Structural Insights into Acetylated-Histone H4 Recognition by the Bromodomain-PHD Finger Module of Human Transcriptional Coactivator CBP
Alexander N. Plotnikov et al.
STRUCTURE (2014)
Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomain
Apirat Chaikuad et al.
MEDCHEMCOMM (2014)
Evaluation of functional groups as acetyl-lysine mimetics for BET bromodomain inhibition
Phillip P. Sharp et al.
MEDCHEMCOMM (2014)
1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain
Emmanuel H. Demont et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
Mathew P. Martin et al.
ACS CHEMICAL BIOLOGY (2013)
4-Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading
Xavier Lucas et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Readout of Epigenetic Modifications
Dinshaw J. Patel et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
Fleur M. Ferguson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
David S. Hewings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains
Guangtao Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Target validation using chemical probes
Mark E. Bunnage et al.
NATURE CHEMICAL BIOLOGY (2013)
RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
Kevin G. McLure et al.
PLOS ONE (2013)
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
Sarah Picaud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
Panagis Filippakopoulos et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
Lewis R. Vidler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions
David S. Hewings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
Paul V. Fish et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain
Ballachanda N. Devaiah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in Cardiomyocytes
Jagat C. Borah et al.
CHEMISTRY & BIOLOGY (2011)
3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
David S. Hewings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Rational Design of Cyclic Peptide Modulators of the Transcriptional Coactivator CBP: A New Class of p53 Inhibitors
Guillermo Gerona-Navarro et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Structural Basis and Specificity of Acetylated Transcription Factor GATA1 Recognition by BET Family Bromodomain Protein Brd3
Roland Gamsjaeger et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery
Martin Philpott et al.
MOLECULAR BIOSYSTEMS (2011)
Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes
Janine M. Lamonica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation
Philip Cohen
BIOCHEMICAL JOURNAL (2010)
Probing the Probes: Fitness Factors For Small Molecule Tools
Paul Workman et al.
CHEMISTRY & BIOLOGY (2010)
Privileged scaffolds for library design and drug discovery
Matthew E. Welsch et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
The art of the chemical probe
Stephen V. Frye
NATURE CHEMICAL BIOLOGY (2010)
Cooperative binding of two acetylation marks on a histone tail by a single bromodomain
Jeanne Moriniere et al.
NATURE (2009)
The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription
Gary LeRoy et al.
MOLECULAR CELL (2008)
Lysine acetylation: Codified crosstalk with other posttranslational modifications
Xiang-Jiao Yang et al.
MOLECULAR CELL (2008)
Structure and acetyl-lysine recognition of the bromodomain
S. Mujtaba et al.
ONCOGENE (2007)
Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4
Sun Hongbin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-associated factor
Chongfeng Pan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation
Shwu-Yuan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Epigenetics: A landscape takes shape
Aaron D. Goldberg et al.
CELL (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Crystal structure of the human BRD2 bromodomain - Insights into dimerization and recognition of acetylated histone H4
Yoshihiro Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Target structure-based discovery of small molecules that block human p53 and CREB binding protein association
Sachchidanand et al.
CHEMISTRY & BIOLOGY (2006)
Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation
S Mujtaba et al.
MOLECULAR CELL (2004)
Bromodomain: an acetyl-lysine binding domain
L Zeng et al.
FEBS LETTERS (2002)
Structural basis of lysine-acetylated HIV-1 tat recognition by PCAF bromodomain
S Mujtaba et al.
MOLECULAR CELL (2002)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
A chemical switch for inhibitor-sensitive alleles of any protein kinase
AC Bishop et al.
NATURE (2000)
Acetylation: a regulatory modification to rival phosphorylation?
T Kouzarides
EMBO JOURNAL (2000)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)
分享论文
